Treatment outcomes of helical tomotherapy for hepatocellular carcinoma in terms of intermediate-dose spillage

BACKGROUND: Although helical tomotherapy (HT) tends to increase intermediate-dose spillage by increasing of low-dose region, this has not been fully determined in the clinical setting. Therefore, we investigated treatment outcomes of HT for hepatocellular carcinoma (HCC) with respect to intermediate...

Descripción completa

Detalles Bibliográficos
Autores principales: Bae, Sun Hyun, Cho, Kwang Hwan, Kim, Young Seok, Kim, Sang Gyune, Yoo, Jeong-Ju, Lee, Jae Myung, Lee, Min Hee, Lim, Sanghyeok, Jung, Jae Hong, Lim, Sung Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798435/
https://www.ncbi.nlm.nih.gov/pubmed/35116467
http://dx.doi.org/10.21037/tcr-20-2912

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798435/
https://www.ncbi.nlm.nih.gov/pubmed/35116467
http://dx.doi.org/10.21037/tcr-20-2912

Ejemplares similares